Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,579 shares at $0.98 ($4K) on 2022-11-02, disclosed to the SEC on 2022-11-03.
Seasonal sale ($4k) by See Remarks — this insider has traded CLVS in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 2,066 | $2K | 45.1% |
| 2 | $0.98 | 2,513 | $2K | 54.9% |
| Total | $0.98 avg | 4,579 | $4K | 100% |
| Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |